Sunshine Heart’s C-Pulse Device Reaches Treatment Milestone for Heart Failure

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

EDEN PRAIRIE, Minn., June 18, 2013 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) today announced a major milestone for its flagship C-Pulse device. As of today, C-Pulse has been implanted in 25 patients in North America and Germany, representing a cumulative 25 years of active C-Pulse heart failure treatment, or over one billion inflation and deflation cycles. The 25th patient was implanted on June 14, 2013 at German Heart Institute – Berlin (DHZB).

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC